drug_normalized,drug_raw,molecule_chembl_id,target_chembl_id,mechanism_of_action
10 x 10^6 cells,10 x 10^6 cells,CHEMBL39541,CHEMBL2095182,Tubulin inhibitor
2.25 mm xience v® everolimus eluting coronary stent system,2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System,CHEMBL1908360,CHEMBL1902,FK506-binding protein 1A inhibitor
alirocumab,Alirocumab,CHEMBL2109540,CHEMBL2929,Subtilisin/kexin type 9 inhibitor
alirocumab 150 mg/ml subcutaneous injection,Alirocumab 150 MG/ML subcutaneous injection,CHEMBL2109540,CHEMBL2929,Subtilisin/kexin type 9 inhibitor
angiotensin 1-7,Angiotensin 1-7,CHEMBL3545347,CHEMBL3559701,Proto-oncogene Mas agonist
aspirin,Aspirin,CHEMBL25,CHEMBL2094253,Cyclooxygenase inhibitor
aspirin + ticagrelor,Aspirin + Ticagrelor,CHEMBL398435,CHEMBL2001,Purinergic receptor P2Y12 negative allosteric modulator
aspirin 25 mg bid,Aspirin 25 mg bid,CHEMBL25,CHEMBL2094253,Cyclooxygenase inhibitor
aspirin tablet,Aspirin tablet,CHEMBL25,CHEMBL2094253,Cyclooxygenase inhibitor
atenolol,Atenolol,CHEMBL24,CHEMBL213,Beta-1 adrenergic receptor antagonist
axys ex device,Axys EX device,CHEMBL382277,CHEMBL4506,NAD-dependent deacetylase sirtuin 1 inhibitor
bms-823778,BMS-823778,CHEMBL4297457,CHEMBL4235,11-beta-hydroxysteroid dehydrogenase 1 inhibitor
biktarvy,Biktarvy,CHEMBL3989867,CHEMBL3471,Human immunodeficiency virus type 1 integrase inhibitor
bupivacaine liposome,Bupivacaine liposome,CHEMBL1098,CHEMBL2072,Sodium channel protein type IV alpha subunit blocker
canakinumab (acz885),Canakinumab (ACZ885),CHEMBL1201834,CHEMBL1909490,Interleukin-1 beta inhibitor
cangrelor,Cangrelor,CHEMBL334966,CHEMBL2001,Purinergic receptor P2Y12 inhibitor
cardiac rehabilitation,Cardiac Rehabilitation,CHEMBL4297517,CHEMBL3831286,Cardiac myosin inhibitor
cellgram-cli,Cellgram-CLI,CHEMBL225157,CHEMBL5255,Toll-like receptor 4 inhibitor
cholecalciferol,Cholecalciferol,CHEMBL1042,CHEMBL1977,Vitamin D receptor agonist
cilostazol,Cilostazol,CHEMBL799,CHEMBL241,Phosphodiesterase 3A inhibitor
cilostazol 100 mg,Cilostazol 100 mg,CHEMBL799,CHEMBL241,Phosphodiesterase 3A inhibitor
cilostazol 200 mg,Cilostazol 200 mg,CHEMBL799,CHEMBL241,Phosphodiesterase 3A inhibitor
colchicine,Colchicine,CHEMBL107,CHEMBL2095182,Tubulin inhibitor
deb,DEB,CHEMBL1651956,CHEMBL1949,Cyclophilin A inhibitor
dipyridamole 200 mg bid,Dipyridamole 200 mg bid,CHEMBL932,CHEMBL1997,Equilibrative nucleoside transporter 1 inhibitor
dipyridamole 200 mg bid,Dipyridamole 200 mg bid,CHEMBL932,CHEMBL2363066,"3',5'-cyclic phosphodiesterase inhibitor"
dipyridamole 200mg and aspirin 25mg bid:,Dipyridamole 200mg and Aspirin 25mg bid:,CHEMBL25,CHEMBL2094253,Cyclooxygenase inhibitor
endurance evaluation,Endurance Evaluation,CHEMBL1467,CHEMBL1929,Xanthine dehydrogenase inhibitor
everolimus eluting bvs,Everolimus Eluting BVS,CHEMBL1908360,CHEMBL1902,FK506-binding protein 1A inhibitor
evolocumab,Evolocumab,CHEMBL2364655,CHEMBL2929,Subtilisin/kexin type 9 inhibitor
exercise,Exercise,CHEMBL1082607,CHEMBL210,Beta-2 adrenergic receptor agonist
exercise rehabilitation,Exercise Rehabilitation,CHEMBL1082607,CHEMBL210,Beta-2 adrenergic receptor agonist
exercise oxymetry,Exercise oxymetry,CHEMBL1082607,CHEMBL210,Beta-2 adrenergic receptor agonist
ezetimibe,Ezetimibe,CHEMBL1138,CHEMBL2027,Niemann-Pick C1-like protein 1 inhibitor
ezetimibe 10mg,Ezetimibe 10mg,CHEMBL1138,CHEMBL2027,Niemann-Pick C1-like protein 1 inhibitor
ezetrol (ezetimibe),Ezetrol (Ezetimibe),CHEMBL1138,CHEMBL2027,Niemann-Pick C1-like protein 1 inhibitor
fentanyl injection,Fentanyl Injection,CHEMBL1201159,CHEMBL233,Mu opioid receptor agonist
gains framed message,Gains Framed Message,CHEMBL24441,CHEMBL264,Histamine H3 receptor antagonist
gains framed message,Gains Framed Message,CHEMBL24441,CHEMBL231,Histamine H1 receptor agonist
gemfibrozil,Gemfibrozil,CHEMBL457,CHEMBL239,Peroxisome proliferator-activated receptor alpha agonist
heparin,Heparin,CHEMBL4650299,CHEMBL1950,Antithrombin-III activator
implantation of everolimus-eluting stent,Implantation of everolimus-eluting stent,CHEMBL1908360,CHEMBL1902,FK506-binding protein 1A inhibitor
interwoven stent,Interwoven stent,CHEMBL428647,CHEMBL2095182,Tubulin inhibitor
jardiance,Jardiance,CHEMBL2107830,CHEMBL3884,Sodium/glucose cotransporter 2 inhibitor
leqvio,LEQVIO,CHEMBL5095052,CHEMBL4630662,PCSK9 mRNA rnai inhibitor
laser-cut stent,Laser-cut stent,CHEMBL428647,CHEMBL2095182,Tubulin inhibitor
lifestyle modification,Lifestyle modification,CHEMBL4298067,CHEMBL4163,Toll-like receptor 2 antagonist
lomitapide,Lomitapide,CHEMBL2105662,CHEMBL2364681,Microsomal triglyceride transfer protein inhibitor
mln1202,MLN1202,CHEMBL3707228,CHEMBL4015,C-C chemokine receptor type 2 inhibitor
metoprolol,Metoprolol,CHEMBL2356097,CHEMBL213,Beta-1 adrenergic receptor antagonist
midazolam injection,Midazolam injection,CHEMBL655,CHEMBL2093872,GABA-A receptor; anion channel positive allosteric modulator
montelukast sodium,Montelukast Sodium,CHEMBL1200681,CHEMBL1798,Cysteinyl leukotriene receptor 1 antagonist
myocardial perfusion imaging with 10 minute waiting period,Myocardial Perfusion imaging with 10 minute waiting period,CHEMBL3989695,CHEMBL251,Adenosine A2a receptor agonist
nexlizet,Nexlizet,CHEMBL3545313,CHEMBL3720,ATP-citrate synthase inhibitor
niacin/laropiprant combination,Niacin/Laropiprant combination,CHEMBL426559,CHEMBL4427,Prostanoid DP receptor antagonist
nitroglycerin,Nitroglycerin,CHEMBL730,CHEMBL2111348,Soluble guanylate cyclase activator
nitroglycerin 0.4 mg sublingual,Nitroglycerin 0.4 mg sublingual,CHEMBL730,CHEMBL2111348,Soluble guanylate cyclase activator
pactimibe sulfate,Pactimibe sulfate,CHEMBL478858,CHEMBL2782,Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor
pactimibe sulfate,Pactimibe sulfate,CHEMBL478858,CHEMBL4465,Acyl coenzyme A:cholesterol acyltransferase 2 inhibitor
percutaneous transluminal angioplasty,Percutaneous Transluminal Angioplasty,CHEMBL334966,CHEMBL2001,Purinergic receptor P2Y12 inhibitor
placebo (for rimonabant),Placebo (for Rimonabant),CHEMBL111,CHEMBL218,Cannabinoid CB1 receptor antagonist
placebo capsules - end of pci,Placebo capsules - end of PCI,CHEMBL2103863,CHEMBL2093865,Histone deacetylase inhibitor
placebo matching with bms-823778,Placebo matching with BMS-823778,CHEMBL4297457,CHEMBL4235,11-beta-hydroxysteroid dehydrogenase 1 inhibitor
"quantitative coronary angiography, intravascular imaging with percutaneous intervention","Quantitative coronary angiography, intravascular imaging with percutaneous intervention",CHEMBL334966,CHEMBL2001,Purinergic receptor P2Y12 inhibitor
ranolazine,Ranolazine,CHEMBL1404,CHEMBL1980,Sodium channel protein type V alpha subunit blocker
ranolazine,Ranolazine,CHEMBL1404,CHEMBL2072,Sodium channel protein type IV alpha subunit blocker
remodulin (treprostinil sodium) injection,Remodulin (treprostinil sodium) Injection,CHEMBL561157,CHEMBL1995,Prostanoid IP receptor agonist
remodulin® (treprostinil sodium) injection,Remodulin® (treprostinil sodium) Injection,CHEMBL561157,CHEMBL1995,Prostanoid IP receptor agonist
repatha,Repatha,CHEMBL2364655,CHEMBL2929,Subtilisin/kexin type 9 inhibitor
rimonabant,Rimonabant,CHEMBL111,CHEMBL218,Cannabinoid CB1 receptor antagonist
rosiglitazone,Rosiglitazone,CHEMBL121,CHEMBL235,Peroxisome proliferator-activated receptor gamma agonist
rosuvastatin,Rosuvastatin,CHEMBL1744447,CHEMBL402,HMG-CoA reductase inhibitor
serine proteinase-1 (serp-1),Serine proteinase-1 (Serp-1),CHEMBL4297879,CHEMBL248,Leukocyte elastase inhibitor
sildenafil,Sildenafil,CHEMBL1737,CHEMBL1827,Phosphodiesterase 5A inhibitor
social network feedback,Social Network Feedback,CHEMBL514270,CHEMBL1800,Corticotropin releasing factor receptor 1 antagonist
spironolactone,Spironolactone,CHEMBL1393,CHEMBL1994,Mineralocorticoid receptor antagonist
temsirolimus,Temsirolimus,CHEMBL1201182,CHEMBL1902,FK506-binding protein 1A inhibitor
temsirolimus and dexamethasone sodium phosphate,Temsirolimus and dexamethasone sodium phosphate,CHEMBL2021430,CHEMBL2034,Glucocorticoid receptor agonist
ticagrelor,Ticagrelor,CHEMBL398435,CHEMBL2001,Purinergic receptor P2Y12 negative allosteric modulator
ticagrelor 90mg,Ticagrelor 90mg,CHEMBL398435,CHEMBL2001,Purinergic receptor P2Y12 negative allosteric modulator
treat-to-target strategy,Treat-to-target strategy,CHEMBL6068498,CHEMBL5498507,Polysaccharide conjugated to Tetanus toxoid vaccine antigen
trilipix,TriLipix,CHEMBL981,CHEMBL239,Peroxisome proliferator-activated receptor alpha agonist
yoga intervention,Yoga intervention,CHEMBL334966,CHEMBL2001,Purinergic receptor P2Y12 inhibitor
angioplasty tibial arteries,angioplasty tibial arteries,CHEMBL563646,CHEMBL1881,Prostanoid EP2 receptor agonist
"atorvastatin, aspirin, losartan, amlodipine","atorvastatin, aspirin, losartan, amlodipine",CHEMBL1200402,CHEMBL2095229,Voltage-gated L-type calcium channel blocker
everolimus-eluting stents (promus®),everolimus-eluting stents (PROMUS®),CHEMBL1908360,CHEMBL1902,FK506-binding protein 1A inhibitor
ezetimibe,ezetimibe,CHEMBL1138,CHEMBL2027,Niemann-Pick C1-like protein 1 inhibitor
mycophenolate mofetil,mycophenolate mofetil,CHEMBL1456,CHEMBL2111369,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
niacin/laropiprant,niacin/laropiprant,CHEMBL426559,CHEMBL4427,Prostanoid DP receptor antagonist
olmesartan medoxomil,olmesartan medoxomil,CHEMBL1200692,CHEMBL227,Type-1 angiotensin II receptor antagonist
percutaneous transluminal angioplasty femoro-popliteal,percutaneous transluminal angioplasty femoro-popliteal,CHEMBL334966,CHEMBL2001,Purinergic receptor P2Y12 inhibitor
pregabalin,pregabalin,CHEMBL1059,CHEMBL2363032,Voltage-gated calcium channel modulator
rosiglitazone/placebo,rosiglitazone/placebo,CHEMBL121,CHEMBL235,Peroxisome proliferator-activated receptor gamma agonist
rosuvastatin,rosuvastatin,CHEMBL1744447,CHEMBL402,HMG-CoA reductase inhibitor
tacrolimus,tacrolimus,CHEMBL3989887,CHEMBL1902,FK506-binding protein 1A inhibitor
urokinase,urokinase,CHEMBL1201420,CHEMBL3286,Urokinase-type plasminogen activator exogenous protein
veliflapon (dg-031),veliflapon (DG-031),CHEMBL88712,CHEMBL4550,5-lipoxygenase activating protein inhibitor
vonapanitase,vonapanitase,CHEMBL3545070,CHEMBL3713712,Elastin proteolytic enzyme
zotarolimus-eluting stent (endeavor®),zotarolimus-eluting stent (ENDEAVOR®),CHEMBL219410,CHEMBL1902,FK506-binding protein 1A inhibitor
